Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Sell
36
ELMD Quote, Financials, Valuation and Earnings
Last price:
$23.83
Seasonality move
:
-9.6%
Day range:
$23.47 - $23.94
52-week range:
$17.73 - $30.73
Dividend yield:
0%
P/E ratio:
23.20x
P/S ratio:
3.03x
P/B ratio:
4.34x
Volume:
27.1K
Avg. volume:
86.1K
1-year change:
-5.28%
Market cap:
$197.3M
Revenue:
$64M
EPS (TTM):
$1.03
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
ELMD
Electromed, Inc.
|
$18M | -- | 11.79% | -- | $37.00 |
|
CNMD
CONMED Corp.
|
$366.9M | $1.32 | -2.76% | 322.31% | $47.40 |
|
ESMC
Escalon Medical Corp.
|
-- | -- | -- | -- | -- |
|
GTHP
Guided Therapeutics, Inc.
|
-- | -- | -- | -- | -- |
|
IRIX
IRIDEX Corp.
|
$14.7M | -$0.02 | 10.68% | -50.4% | $3.00 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
ELMD
Electromed, Inc.
|
$23.84 | $37.00 | $197.3M | 23.20x | $0.00 | 0% | 3.03x |
|
CNMD
CONMED Corp.
|
$38.40 | $47.40 | $1.2B | 25.34x | $0.20 | 2.08% | 0.87x |
|
ESMC
Escalon Medical Corp.
|
$0.25 | -- | $1.9M | 154.45x | $0.00 | 0% | 0.22x |
|
GTHP
Guided Therapeutics, Inc.
|
$0.29 | -- | $24.2M | -- | $0.00 | 0% | 118.26x |
|
IRIX
IRIDEX Corp.
|
$1.34 | $3.00 | $23M | -- | $0.00 | 0% | 0.44x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
ELMD
Electromed, Inc.
|
-- | 0.818 | -- | 4.40x |
|
CNMD
CONMED Corp.
|
46.21% | 0.021 | 70.58% | 0.94x |
|
ESMC
Escalon Medical Corp.
|
31.63% | 2.303 | 43.39% | 1.03x |
|
GTHP
Guided Therapeutics, Inc.
|
-74.91% | 3.985 | 11.94% | 0.01x |
|
IRIX
IRIDEX Corp.
|
50.55% | 0.352 | 18.81% | 1.03x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
ELMD
Electromed, Inc.
|
$14.8M | $3.6M | 20.33% | 20.35% | 19.16% | $2.4M |
|
CNMD
CONMED Corp.
|
$213.3M | $66.9M | 2.49% | 4.72% | 17.91% | $41.2M |
|
ESMC
Escalon Medical Corp.
|
$1.6M | $98.7K | -10.13% | -12.94% | 2.75% | -$517.4K |
|
GTHP
Guided Therapeutics, Inc.
|
$8K | -$485K | -- | -- | -808.33% | -$279K |
|
IRIX
IRIDEX Corp.
|
$4M | -$1.4M | -54.1% | -155.93% | -11.3% | -$1.2M |
Electromed, Inc. vs. Competitors
-
Which has Higher Returns ELMD or CNMD?
CONMED Corp. has a net margin of 14.61% compared to Electromed, Inc.'s net margin of 4.48%. Electromed, Inc.'s return on equity of 20.35% beat CONMED Corp.'s return on equity of 4.72%.
Company Gross Margin Earnings Per Share Invested Capital ELMDElectromed, Inc.78.42% $0.32 $45.4M CNMDCONMED Corp.57.12% $0.54 $1.9B -
What do Analysts Say About ELMD or CNMD?
Electromed, Inc. has a consensus price target of $37.00, signalling upside risk potential of 55.2%. On the other hand CONMED Corp. has an analysts' consensus of $47.40 which suggests that it could grow by 23.44%. Given that Electromed, Inc. has higher upside potential than CONMED Corp., analysts believe Electromed, Inc. is more attractive than CONMED Corp..
Company Buy Ratings Hold Ratings Sell Ratings ELMDElectromed, Inc.3 0 0 CNMDCONMED Corp.0 5 0 -
Is ELMD or CNMD More Risky?
Electromed, Inc. has a beta of 0.300, which suggesting that the stock is 70.034% less volatile than S&P 500. In comparison CONMED Corp. has a beta of 0.913, suggesting its less volatile than the S&P 500 by 8.698%.
-
Which is a Better Dividend Stock ELMD or CNMD?
Electromed, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. CONMED Corp. offers a yield of 2.08% to investors and pays a quarterly dividend of $0.20 per share. Electromed, Inc. pays -- of its earnings as a dividend. CONMED Corp. pays out 18.82% of its earnings as a dividend. CONMED Corp.'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios ELMD or CNMD?
Electromed, Inc. quarterly revenues are $18.9M, which are smaller than CONMED Corp. quarterly revenues of $373.5M. Electromed, Inc.'s net income of $2.8M is lower than CONMED Corp.'s net income of $16.7M. Notably, Electromed, Inc.'s price-to-earnings ratio is 23.20x while CONMED Corp.'s PE ratio is 25.34x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed, Inc. is 3.03x versus 0.87x for CONMED Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELMDElectromed, Inc.3.03x 23.20x $18.9M $2.8M CNMDCONMED Corp.0.87x 25.34x $373.5M $16.7M
-
Which has Higher Returns ELMD or ESMC?
Escalon Medical Corp. has a net margin of 14.61% compared to Electromed, Inc.'s net margin of 2.72%. Electromed, Inc.'s return on equity of 20.35% beat Escalon Medical Corp.'s return on equity of -12.94%.
Company Gross Margin Earnings Per Share Invested Capital ELMDElectromed, Inc.78.42% $0.32 $45.4M ESMCEscalon Medical Corp.43.33% $0.01 $2.6M -
What do Analysts Say About ELMD or ESMC?
Electromed, Inc. has a consensus price target of $37.00, signalling upside risk potential of 55.2%. On the other hand Escalon Medical Corp. has an analysts' consensus of -- which suggests that it could grow by 4700%. Given that Escalon Medical Corp. has higher upside potential than Electromed, Inc., analysts believe Escalon Medical Corp. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ELMDElectromed, Inc.3 0 0 ESMCEscalon Medical Corp.0 0 0 -
Is ELMD or ESMC More Risky?
Electromed, Inc. has a beta of 0.300, which suggesting that the stock is 70.034% less volatile than S&P 500. In comparison Escalon Medical Corp. has a beta of 0.232, suggesting its less volatile than the S&P 500 by 76.837%.
-
Which is a Better Dividend Stock ELMD or ESMC?
Electromed, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Escalon Medical Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed, Inc. pays -- of its earnings as a dividend. Escalon Medical Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ELMD or ESMC?
Electromed, Inc. quarterly revenues are $18.9M, which are larger than Escalon Medical Corp. quarterly revenues of $3.6M. Electromed, Inc.'s net income of $2.8M is higher than Escalon Medical Corp.'s net income of $97.7K. Notably, Electromed, Inc.'s price-to-earnings ratio is 23.20x while Escalon Medical Corp.'s PE ratio is 154.45x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed, Inc. is 3.03x versus 0.22x for Escalon Medical Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELMDElectromed, Inc.3.03x 23.20x $18.9M $2.8M ESMCEscalon Medical Corp.0.22x 154.45x $3.6M $97.7K
-
Which has Higher Returns ELMD or GTHP?
Guided Therapeutics, Inc. has a net margin of 14.61% compared to Electromed, Inc.'s net margin of -1236.67%. Electromed, Inc.'s return on equity of 20.35% beat Guided Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital ELMDElectromed, Inc.78.42% $0.32 $45.4M GTHPGuided Therapeutics, Inc.13.33% -$0.01 -$3.2M -
What do Analysts Say About ELMD or GTHP?
Electromed, Inc. has a consensus price target of $37.00, signalling upside risk potential of 55.2%. On the other hand Guided Therapeutics, Inc. has an analysts' consensus of -- which suggests that it could grow by 38620589.66%. Given that Guided Therapeutics, Inc. has higher upside potential than Electromed, Inc., analysts believe Guided Therapeutics, Inc. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ELMDElectromed, Inc.3 0 0 GTHPGuided Therapeutics, Inc.0 0 0 -
Is ELMD or GTHP More Risky?
Electromed, Inc. has a beta of 0.300, which suggesting that the stock is 70.034% less volatile than S&P 500. In comparison Guided Therapeutics, Inc. has a beta of 0.568, suggesting its less volatile than the S&P 500 by 43.187%.
-
Which is a Better Dividend Stock ELMD or GTHP?
Electromed, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Guided Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed, Inc. pays -- of its earnings as a dividend. Guided Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ELMD or GTHP?
Electromed, Inc. quarterly revenues are $18.9M, which are larger than Guided Therapeutics, Inc. quarterly revenues of $60K. Electromed, Inc.'s net income of $2.8M is higher than Guided Therapeutics, Inc.'s net income of -$742K. Notably, Electromed, Inc.'s price-to-earnings ratio is 23.20x while Guided Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed, Inc. is 3.03x versus 118.26x for Guided Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELMDElectromed, Inc.3.03x 23.20x $18.9M $2.8M GTHPGuided Therapeutics, Inc.118.26x -- $60K -$742K
-
Which has Higher Returns ELMD or IRIX?
IRIDEX Corp. has a net margin of 14.61% compared to Electromed, Inc.'s net margin of -12.6%. Electromed, Inc.'s return on equity of 20.35% beat IRIDEX Corp.'s return on equity of -155.93%.
Company Gross Margin Earnings Per Share Invested Capital ELMDElectromed, Inc.78.42% $0.32 $45.4M IRIXIRIDEX Corp.32.15% -$0.09 $9.5M -
What do Analysts Say About ELMD or IRIX?
Electromed, Inc. has a consensus price target of $37.00, signalling upside risk potential of 55.2%. On the other hand IRIDEX Corp. has an analysts' consensus of $3.00 which suggests that it could grow by 123.88%. Given that IRIDEX Corp. has higher upside potential than Electromed, Inc., analysts believe IRIDEX Corp. is more attractive than Electromed, Inc..
Company Buy Ratings Hold Ratings Sell Ratings ELMDElectromed, Inc.3 0 0 IRIXIRIDEX Corp.1 0 0 -
Is ELMD or IRIX More Risky?
Electromed, Inc. has a beta of 0.300, which suggesting that the stock is 70.034% less volatile than S&P 500. In comparison IRIDEX Corp. has a beta of 0.674, suggesting its less volatile than the S&P 500 by 32.591%.
-
Which is a Better Dividend Stock ELMD or IRIX?
Electromed, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. IRIDEX Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Electromed, Inc. pays -- of its earnings as a dividend. IRIDEX Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios ELMD or IRIX?
Electromed, Inc. quarterly revenues are $18.9M, which are larger than IRIDEX Corp. quarterly revenues of $12.5M. Electromed, Inc.'s net income of $2.8M is higher than IRIDEX Corp.'s net income of -$1.6M. Notably, Electromed, Inc.'s price-to-earnings ratio is 23.20x while IRIDEX Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Electromed, Inc. is 3.03x versus 0.44x for IRIDEX Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income ELMDElectromed, Inc.3.03x 23.20x $18.9M $2.8M IRIXIRIDEX Corp.0.44x -- $12.5M -$1.6M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Buy
54
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 38x
Sell
46
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.7T
P/E Ratio: 29x
Alerts
Buy
52
PZZA alert for Mar 12
Papa John's International, Inc. [PZZA] is down 1.96% over the past day.
Buy
53
NBIS alert for Mar 12
Nebius Group NV [NBIS] is down 3.53% over the past day.
Buy
88
NBTX alert for Mar 12
Nanobiotix SA [NBTX] is down 4.84% over the past day.
